Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO) announced that Anish Bhatnagar, M.D., Chief Executive Officer will participate in a fireside chat at the Piper Sandler 37th Healthcare Conference on Thursday, December 4, 2025 at 9:00 AM ET.

A live audio webcast and replay will be available in the Investors section of the company website at www.soleno.life.

News Market Reaction

+1.77%

32 alerts

+1.77% News Effect

+2.6% Peak in 3 hr 48 min

+$47M Valuation Impact

$2.70B Market Cap

0.8x Rel. Volume

On the day this news was published, SLNO gained 1.77%, reflecting a mild positive market reaction. Argus tracked a peak move of +2.6% during that session. Our momentum scanner triggered 32 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $47M to the company's valuation, bringing the market cap to $2.70B at that time.

Data tracked by StockTitan Argus on the day of publication.

REDWOOD CITY, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37^th Healthcare Conference on Thursday, December 4, 2025, at 9:00 AM Eastern Time.

A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578

FAQ

When will Soleno Therapeutics (SLNO) present at the Piper Sandler 37th Healthcare Conference?

Soleno's CEO will present on Thursday, December 4, 2025 at 9:00 AM ET.

Who from Soleno Therapeutics (SLNO) will participate in the Piper Sandler conference?

Anish Bhatnagar, M.D., Chief Executive Officer, will participate in a fireside chat.

How can investors access the Soleno Therapeutics (SLNO) Piper Sandler presentation?

A live audio webcast and a replay will be available in the Investors section at www.soleno.life.

Will Soleno Therapeutics (SLNO) publish a replay of the Piper Sandler presentation?

Yes. The company said a replay of the presentation will be available on its investor website.

What topics will Soleno Therapeutics (SLNO) cover in the CEO fireside chat on December 4, 2025?

The announcement only confirms the CEO will participate in a fireside chat; no specific topics were disclosed.